(Moderna) Moderna Inc. has announced that the currently authorized 50 µg booster dose increased neutralizing antibodies against the Omicron by about 37 times. The 100-µg dose raised the neutralizing antibodies…
(IHS Markit) The Eurozone Composite Output Index fell to a nine-month low of 53.4 in December, suggesting slowed activity in the economy. Renewed Covid-19 infections saw the service sector slow…
(WSJ) S&P 500 futures fell about 1.6%, while the Dow Jones Industrial Average traded 2.2% lower on Friday on fresh concerns of the spread of a new strain of coronavirus…
(Merck) Merck stock fell more than 3% on Friday in premarket after an updated study of its investigational oral antiviral pill, molnupiravir, against COVID-19 showed lower efficacy rates. A MOVe-OUT…
(Moderna) US Food and Drug Administration has extended the emergency use authorization of Moderna’s booster vaccine shot against Covid-19. The booster dose will be used on all individuals 18 years…
(Regeneron) Regeneron Pharmaceuticals Inc. has announced that a single dose of its antibody cocktail, REGEN-COV, minimized the risk of contracting Covid-19 by 81.6%. The efficacy results came from a late-stage…
(Pfizer) Pfizer Inc. has announced that its novel Covid-19 antiviral drug candidate PAXLOVID reduces the risk of death or hospitalization by 89%. In an interim study, Pfizer found that no…
(Reuters) Molnupiravir, a Covid-19 antiviral pill developed by Merck and Ridgeback Biotherapeutics, has been approved by Britain’s regulator, becoming the first in the world. Britain's Medicines and Healthcare products Regulatory…
(Sorrento) Sorrento Therapeutics Inc. has announced an 81% sensitivity by COVISTIX for screening both symptomatic and asymptomatic Covid-19 infections. The 81% sensitivity is a superior rate compared to 62% reported…
(Bloomberg) South Korea’s regulators have fined Google $177 million for blocking rivals from its Android operating system. Fig: Android Dominance The South Korea’s regulator says Google’s actions sustain its dominance…
(Valneva) Specialty vaccine maker Valneva SE suffered a blow after the UK exercised a provision allowing it to terminate a supply deal for Covid-19 vaccines. The UK government cites a…
(Humanigen) US Food and Drug Administration has declined to grant an emergency use authorization for Humanigen’s Lenzilumab for use by hospitalized Covid-19 patients. FDA says it is unable to conclusively…